Free Trial
OTCMKTS:PHGUF

Pharming Group (PHGUF) Stock Price, News & Analysis

Pharming Group logo
$1.15 0.00 (0.00%)
As of 06/27/2025

About Pharming Group Stock (OTCMKTS:PHGUF)

Key Stats

Today's Range
$1.15
$1.15
50-Day Range
$0.89
$1.19
52-Week Range
$0.75
$1.19
Volume
N/A
Average Volume
74 shs
Market Capitalization
$771.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Receive PHGUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter.

PHGUF Stock News Headlines

Pharming Group (PHGN.DU)
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

PHGUF Stock Analysis - Frequently Asked Questions

Pharming Group's stock was trading at $0.9815 at the beginning of 2025. Since then, PHGUF shares have increased by 17.2% and is now trading at $1.15.
View the best growth stocks for 2025 here
.

Pharming Group NV (OTCMKTS:PHGUF) issued its earnings results on Thursday, March, 5th. The biotechnology company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.04 by $0.01. Pharming Group had a negative net margin of 4.14% and a negative trailing twelve-month return on equity of 6.01%.

Shares of PHGUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
3/05/2015
Today
6/30/2025
Next Earnings (Estimated)
7/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
N/A
Current Symbol
OTCMKTS:PHGUF
Previous Symbol
OTC:PHGUF
CIK
N/A
Employees
382
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.84 million
Pretax Margin
-1.14%

Debt

Sales & Book Value

Annual Sales
$297.20 million
Price / Cash Flow
N/A
Book Value
$0.33 per share
Price / Book
3.48

Miscellaneous

Free Float
N/A
Market Cap
$771.73 million
Optionable
Not Optionable
Beta
0.55

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:PHGUF) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners